This article {extract} was published in Communicable Diseases Intelligence Vol 30 No 1 March 2006 and may be downloaded as a full version PDF from the Table of contents page.
Results, continued
Other communicable disease surveillance
Laboratory Virology and Serology Reporting Scheme
The Laboratory Virology and Serology Reporting Scheme (LabVISE) is a passive surveillance scheme based on voluntary reports of infectious agents from sentinel virology and serology laboratories around Australia. LabVISE provides data on diagnoses of a number of infectious viruses, parasites and fungi. Interpretation of data from LabVISE is limited by uncertainties regarding its representativeness, lack of denominator data to calculate positivity rates, variable reporting coverage over time and lack of consistent case definitions. LabVISE has an important role in supplementing information of diseases under surveillance in NNDSS and in monitoring infectious agents that are not reported by other surveillance systems.
In 2004, a total of 12 laboratories reported 26,218 infectious agents to LabVISE. This represents a 14 per cent increase in the number of reports received in 2004 compared to 2003 (Table 27). Most of the reports were from South Australia (30%), Queensland (27%) and Western Australia (16%) (Table 27).
Table 27. Infectious agents reported to the Laboratory Virology and Serology Reporting Scheme, 2004, by state or territory
| State or territory | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Organism |
ACT | NSW | NT | Qld | SA | Tas | Vic | WA | Total 2004 | Total 2003 |
| Measles virus | 0 |
3 |
1 |
5 |
6 |
0 |
12 |
8 |
35 |
71 |
| Mumps virus | 0 |
0 |
0 |
1 |
2 |
0 |
1 |
2 |
6 |
10 |
| Rubella virus | 0 |
3 |
0 |
8 |
2 |
0 |
2 |
5 |
20 |
26 |
| Hepatitis A virus | 0 |
7 |
3 |
16 |
6 |
0 |
5 |
14 |
51 |
87 |
| Hepatitis D virus | 0 |
1 |
0 |
2 |
2 |
0 |
1 |
2 |
8 |
19 |
| Hepatitis E virus | 0 |
0 |
0 |
0 |
0 |
0 |
12 |
2 |
14 |
– |
| Ross River virus | 0 |
19 |
16 |
608 |
44 |
3 |
19 |
34 |
743 |
1,239 |
| Barmah Forest virus | 1 |
14 |
2 |
153 |
14 |
0 |
2 |
9 |
195 |
408 |
| Alphavirus (unspecified) | 0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
– |
| Dengue | 0 |
0 |
5 |
0 |
1 |
0 |
0 |
6 |
12 |
35 |
| Flavivirus (unspecified) | 0 |
1 |
7 |
81 |
0 |
0 |
12 |
1 |
102 |
122 |
| Adenovirus type 40 | 0 |
0 |
1 |
0 |
0 |
0 |
0 |
30 |
31 |
32 |
| Adenovirus not typed/pending | 10 |
247 |
3 |
78 |
438 |
5 |
165 |
105 |
1,051 |
928 |
| Herpes virus type 6 | 0 |
2 |
0 |
0 |
0 |
0 |
4 |
0 |
6 |
5 |
| Cytomegalovirus | 8 |
374 |
6 |
108 |
226 |
17 |
94 |
1 |
834 |
859 |
| Varicella-zoster virus | 1 |
161 |
23 |
928 |
469 |
9 |
73 |
397 |
2,061 |
1,715 |
| Epstein-Barr virus | 0 |
93 |
60 |
771 |
1,119 |
3 |
41 |
280 |
2,367 |
1,719 |
| Other DNA viruses | 0 |
15 |
0 |
111 |
33 |
3 |
67 |
194 |
423 |
279 |
| Picornavirus family | 7 |
502 |
5 |
21 |
105 |
3 |
83 |
238 |
964 |
805 |
| Ortho/ paramyxoviruses | 5 |
1,329 |
13 |
330 |
1,255 |
60 |
403 |
729 |
4,124 |
4,568 |
| Other RNA viruses | 0 |
294 |
29 |
2 |
457 |
119 |
855 |
804 |
2,560 |
1,801 |
| Chlamydia trachomatis | 39 |
691 |
13 |
1,929 |
1,689 |
36 |
61 |
801 |
5,259 |
4,298 |
| Chlamydia pneumoniae | 0 |
1 |
0 |
0 |
1 |
0 |
5 |
2 |
9 |
15 |
| Chlamydia psittaci | 2 |
3 |
0 |
2 |
6 |
0 |
159 |
1 |
173 |
118 |
| Chlamydia species (untyped) | 0 |
3 |
0 |
0 |
0 |
0 |
1 |
1 |
5 |
2 |
| Mycoplasma pneumoniae | 1 |
111 |
23 |
475 |
381 |
15 |
321 |
47 |
1,374 |
1,146 |
| Mycoplasma hominis | 0 |
4 |
0 |
0 |
1 |
0 |
0 |
0 |
5 |
9 |
| Coxiella burnetii (Q fever) | 1 |
3 |
3 |
30 |
115 |
0 |
17 |
4 |
173 |
178 |
| Rickettsia prowazeki | 0 |
0 |
0 |
0 |
102 |
0 |
0 |
1 |
103 |
3 |
| Rickettsia tsutsugamushi | 0 |
0 |
0 |
0 |
64 |
0 |
1 |
2 |
67 |
4 |
| Rickettsia – spotted fever group | 0 |
0 |
0 |
0 |
136 |
3 |
0 |
0 |
139 |
2 |
| Streptococcus group A | 0 |
7 |
1 |
320 |
0 |
0 |
139 |
0 |
467 |
490 |
| Yersinia enterocolitica | 0 |
8 |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
12 |
| Brucella abortus | 0 |
0 |
0 |
0 |
2 |
0 |
4 |
0 |
6 |
5 |
| Brucella species | 0 |
4 |
0 |
5 |
0 |
0 |
0 |
0 |
9 |
7 |
| Bordetella pertussis | 6 |
68 |
0 |
170 |
549 |
2 |
270 |
293 |
1,358 |
520 |
| Bordetella parapertussis | 0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
– |
| Legionella pneumophila | 0 |
9 |
0 |
0 |
8 |
0 |
59 |
1 |
77 |
132 |
| Legionella longbeachae | 0 |
3 |
0 |
0 |
26 |
1 |
25 |
21 |
76 |
84 |
| Legionella species | 0 |
4 |
0 |
1 |
0 |
0 |
10 |
0 |
15 |
18 |
| Cryptococcus species | 0 |
2 |
0 |
7 |
29 |
0 |
0 |
0 |
38 |
26 |
| Leptospira species | 0 |
0 |
0 |
20 |
3 |
0 |
0 |
0 |
23 |
24 |
| Borrelia burgdorferi | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
– |
| Treponema pallidum | 1 |
159 |
0 |
535 |
447 |
0 |
3 |
9 |
1,154 |
1,168 |
| Entamoeba histolytica | 0 |
0 |
0 |
2 |
0 |
1 |
10 |
1 |
14 |
14 |
| Toxoplasma gondii | 0 |
11 |
0 |
4 |
11 |
2 |
10 |
3 |
41 |
41 |
| Echinococcus granulosus | 0 |
0 |
0 |
0 |
13 |
0 |
2 |
0 |
15 |
21 |
| Total | 82 |
4,156 |
215 |
6,723 |
7,762 |
282 |
2,949 |
4,049 |
26,218 |
23,065 |
Sixty per cent (n=15,608) of all reports received by LabVISE were viral infectious agents, and the remaining 40 per cent (n=10,610) were bacterial or other infectious agents. Among viruses, herpes viruses (33.5%; 5,268) were the most commonly reported followed by ortho/paramyxoviruses (27%; 4,124) which includes influenza, parainfluenza and respiratory syncytial viruses (Figure 67). Among non-viral infectious agents, Chlamydia trachomatis (52%; 5,259), Mycoplasma pneumoniae (13%; 1,374) and Bordetella pertussis (13%; 1,358) were the most commonly reported pathogens.
Figure 67. Reports of viral infections to the Laboratory Virology and Serology Reporting Scheme, 2004, by viral group
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 30 No 1, March 2006
NNDSS Annual report 2004
Communicable Diseases Intelligence